Diffraction from Microvolume Topaz Microprocessors

Information

  • Research Project
  • 6789208
  • ApplicationId
    6789208
  • Core Project Number
    R41GM071326
  • Full Project Number
    1R41GM071326-01
  • Serial Number
    71326
  • FOA Number
  • Sub Project Id
  • Project Start Date
    7/10/2004 - 21 years ago
  • Project End Date
    6/30/2005 - 20 years ago
  • Program Officer Name
    EDMONDS, CHARLES G.
  • Budget Start Date
    7/10/2004 - 21 years ago
  • Budget End Date
    6/30/2005 - 20 years ago
  • Fiscal Year
    2004
  • Support Year
    1
  • Suffix
  • Award Notice Date
    7/5/2004 - 21 years ago
Organizations

Diffraction from Microvolume Topaz Microprocessors

DESCRIPTION (provided by applicant): We propose to develop an efficient and rapid X-ray diffraction screen for protein crystals that will accelerate structure determination of proteins that are difficult to express and purify. Determination of protein structures at atomic resolution has allowed major advances in our fundamental understanding of biology and has provided a basis for rational drug design. However, a major obstacle to determining protein structures by X-ray crystallography has been in the initial step of identifying X-ray diffracting protein crystals. Current methods that identify protein crystals primarily by morphology followed by diffraction are costly in terms of time and material. We will modify the Fluidigm Topaz crystallization chip so that protein crystals can be screened in situ for X-ray diffraction at a synchrotron. We will optimize the material composition of the chip to maximize X-ray transparency while maintaining the functional ability to crystallize proteins. We will then develop the parameters to differentiate protein and contaminating salt crystals that are as small as 10 microns. We will collaborate with multiple structural biologists to utilize the diffraction screen with a wide variety of transmembrane, signaling, and enzymatic proteins. We anticipate that the diffraction screen that we will develop will be easily adapted to other synchrotron facilities and will accelerate crystallographic studies of proteins with scientific and medical importance.

IC Name
NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
  • Activity
    R41
  • Administering IC
    GM
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    115697
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    821
  • Ed Inst. Type
  • Funding ICs
    NIGMS:115697\
  • Funding Mechanism
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    FLUIDIGM CORPORATION
  • Organization Department
  • Organization DUNS
    133223631
  • Organization City
    SOUTH SAN FRANCISCO
  • Organization State
    CA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    94080
  • Organization District
    UNITED STATES